As members of a land grant institution with an outreach mission at its core, Huck faculty and staff are engaged in multiple efforts designed to serve the public interest.
In the midst of this global pandemic, we offer the following services to help better inform world citizenry with scientifically valid information about coronavirus and related research efforts:
Our Center for Infectious Disease Dynamics (CIDD) is comprised of more than 50 faculty experts in infectious disease, including many scientists that are modeling the pandemic, studying virus transmission, advising governments and the health industry, and developing diagnostics, vaccines and therapeutics. To better inform the public during this time of global health crisis, CIDD faculty have partnered with Huck’s communications team to launch the Ask CIDD initiative.
This initiative posts answers to the public’s most commonly asked questions about COVID-19, using the most current research based on accurate, fact-supported science.
Each week, new questions are answered in print format here.
Additionally, popular questions are periodically answered via video here.
You can submit your own questions and view answers here.
The Symbiotic Podcast
Launched in Fall 2019, this Huck-produced monthly podcast focuses on stories of cross-disciplinary life sciences research stories.
In light of the coronavirus pandemic, Season 2 of the series presents COVID-19 Research Briefs to keep subscribers informed about the latest developments in related research at Penn State and beyond.
View all related audio, videos, transcripts, guest bios, and subscription options at www.thesymbioticpodcast.com
Data 4 Action
Data 4 Action is a collaboration between Penn State, local government, and community organizations to better assess and address impacts and risk factors associated with the coronavirus pandemic in Centre County. The project involves an initial anonymous online survey to collect demographic and behavioral information from county residents, a second study that will survey returning Penn State students, and a third planned study to track and serologically test a smaller number of individuals over multiple years.